| KD price | $13.92 at the August 3, 2026, 4:00 PM EDT market close, up 0.37 or 2.73% from the $13.55 July 31 close, after opening at $13.94 and trading in a session range of $13.89 to $14.19, with the daily history table confirming the $13.92 close on volume near 4.42 million shares and an after-hours quote of $13.78 down 0.14 or 1.01% | StockAnalysis.com real-time quote and daily price history | August 4, 2026 |
| Market capitalization | Near $3.07 billion, reported by StockAnalysis.com at the August 3, 2026 market close and matching the $13.92 price times 220.52 million shares outstanding, with 220,517,208 shares outstanding as of the June 3, 2026 record date for the July 30, 2026 annual meeting | StockAnalysis.com quote and statistics, Kyndryl annual meeting record date | August 4, 2026 |
| Fiscal 2026 revenue | $15.092 billion for the year ended March 31, 2026, up 0.23% from $15.057 billion in fiscal 2025, flat on a reported basis and down 3% in constant currency, matching StockAnalysis.com, Macrotrends, and the fiscal 2026 Form 10-K | StockAnalysis.com financials, Macrotrends, Kyndryl fiscal 2026 Form 10-K | August 4, 2026 |
| Fiscal 2026 earnings | Pretax income of $414 million versus $435 million in fiscal 2025, net income of $198 million or $0.85 per diluted share versus $252 million or $1.05, adjusted pretax income of $581 million up 21% from $482 million, adjusted net income of $341 million or $1.46 per diluted share versus $285 million or $1.19, and adjusted EBITDA of $2.7 billion up 6% | Kyndryl fourth quarter and full-year 2026 earnings release, May 6, 2026 | August 4, 2026 |
| Fiscal 2027 outlook | Adjusted pretax income of $600 million to $700 million, free cash flow of $400 million to $500 million, and constant-currency revenue flat to down 2% | Kyndryl fourth quarter and full-year 2026 earnings release, May 6, 2026 | August 4, 2026 |
| Fiscal 2026 cash flow | Cash flow from operations of $948 million versus $942 million in fiscal 2025, free cash flow of $406 million versus $419 million, and fourth quarter cash flow from operations of $499 million | Kyndryl fourth quarter and full-year 2026 earnings release and fiscal 2026 Form 10-K | August 4, 2026 |
| Fiscal 2026 signings | Signings of $13.5 billion including 38 contracts in excess of $50 million, with more than 30% of large-deal value from new scope and new logos, up from about 15% in the prior year | Kyndryl fourth quarter and full-year 2026 earnings release | August 4, 2026 |
| Hyperscaler and Consult revenue | Hyperscaler-related revenue of $1.9 billion in fiscal 2026, up 59% year over year and above the $1.8 billion target, and Kyndryl Consult revenue of $3.5 billion, up 18%, with Consult signings of $4 billion | Kyndryl fourth quarter and full-year 2026 earnings release | August 4, 2026 |
| Segment revenue | United States revenue of $3.784 billion down 2%, Japan of $2.284 billion down 3%, Principal Markets of $5.399 billion up 4%, and Strategic Markets of $3.625 billion flat, per the fiscal 2026 Form 10-K | Kyndryl fiscal 2026 Form 10-K segment results | August 4, 2026 |
| Segment adjusted EBITDA | United States adjusted EBITDA of $835 million up 15%, Japan of $486 million up 25%, Principal Markets of $834 million down 6%, Strategic Markets of $622 million up 3%, Corporate and other of negative $105 million, and total adjusted EBITDA of $2.672 billion up 6% | Kyndryl fiscal 2026 Form 10-K segment results | August 4, 2026 |
| Balance sheet | Cash and cash equivalents of $2.623 billion, total debt of $4.956 billion including about $1 billion drawn on the revolving credit facility, net cash of negative $2.333 billion or about $10.58 per share, shareholders equity of $1.293 billion, book value per share of $5.28, working capital of negative $779 million, and current ratio of 0.88 as of March 31, 2026 | StockAnalysis.com statistics and balance sheet, Kyndryl fiscal 2026 Form 10-K | August 4, 2026 |
| Debt structure | Senior notes of $700 million at 2.05% due October 2026, $500 million at 2.70% due 2028, $650 million at 3.15% due 2031, $500 million at 6.35% due 2034, and $550 million at 4.10% due 2041, plus finance leases, with the $700 million notes due 2026 still requiring refinancing | Kyndryl fiscal 2026 Form 10-K borrowings note | August 4, 2026 |
| Valuation | PE ratio of 16.38, forward PE of 7.36, price-to-sales of 0.20, price-to-book of 2.64, price-to-free-cash-flow of 9.03, enterprise value of $5.40 billion, EV/EBITDA of 1.65, debt/equity of 3.84, and Altman Z-Score of 1.44 | StockAnalysis.com statistics, verified with financial_rigor.py | August 4, 2026 |
| Analyst consensus | Hold with an average price target of $13.60 across 6 analysts, low of $13 and high of $15, median $13, with 0 Strong Buy, 0 Buy, 5 Hold, and 1 Sell in the July 2026 recommendation trend | StockAnalysis.com forecast and analyst ratings | August 4, 2026 |
| Recent analyst target updates | BMO Capital maintained Hold with a $15 to $14 target cut on July 22, 2026, Scotiabank moved $17 to $15 on May 7, 2026, Susquehanna downgraded to Hold at $13 on May 21, 2026, and Morgan Stanley cut $28 to $13 on March 24, 2026 | StockAnalysis.com forecast and ratings | August 4, 2026 |
| Consensus estimates | Fiscal 2027 revenue estimate of $14.91 billion with adjusted EPS of $1.89, and fiscal 2028 revenue of $15.00 billion with adjusted EPS of $2.59 | StockAnalysis.com forecast financial forecast | August 4, 2026 |
| Short interest | 32.38 million shares short, 14.68% of shares outstanding and 15.81% of float, 7.17 days to cover, up from 27.95 million shares the prior month | StockAnalysis.com statistics short selling | August 4, 2026 |
| Share repurchases | Kyndryl repurchased 11.6 million shares for $304 million in fiscal 2026, and 14.3 million shares for $398 million since the November 2024 authorization, or about 6% of shares outstanding, with about $302 million of capacity remaining | Kyndryl fourth quarter and full-year 2026 earnings release | August 4, 2026 |
| Material weaknesses | The fiscal 2026 Form 10-K reports material weaknesses in internal control over financial reporting, including senior finance executives failing to set an appropriate tone at the top with a lack of transparency related to cash management practices, ineffective disclosure process communication, and weak controls over the internal investigation and escalation of hotline complaints, with a remediation plan targeting March 31, 2027 | Kyndryl fiscal 2026 Form 10-K Item 9A, PwC report | August 4, 2026 |
| Restatement filings | Kyndryl filed Form 10-K/A and Form 10-Q/A on February 17, 2026 to restate managements internal control conclusions for fiscal 2025 and the interim period, while concluding the previously issued financial statements were still fairly presented | SEC EDGAR Kyndryl Form 10-K/A and Form 10-Q/A filings | August 4, 2026 |
| Officer changes | Interim CFO Harsh Chugh and interim controller Bhavna Doegar appointed February 5, 2026; new CFO Ellen Johnson, former Interpublic executive vice president and chief financial officer, appointed July 1, 2026 with the role effective August 6, 2026; Andrew Bonzani joined as General Counsel and Secretary on July 6, 2026 | Kyndryl Form 8-K filings February 5 and July 1, 2026 | August 4, 2026 |
| Investigation | Kahn Swick and Foti announced on August 1, 2026 that it had commenced an investigation of the officers and directors of Kyndryl Holdings, Inc. related to the company | Business Wire press release via StockAnalysis.com news feed | August 4, 2026 |
| Solvinity acquisition blocked | The State Secretary for Economic Affairs and Climate Policy in the Netherlands issued a decision on May 25, 2026 prohibiting Kyndryls proposed acquisition of Solvinity Group B.V., a Netherlands managed cloud provider, for cash consideration of approximately 100 million euros, per the fiscal 2026 Form 10-K | Kyndryl fiscal 2026 Form 10-K Note 10 | August 4, 2026 |
| Upcoming earnings | Kyndryl will release first quarter fiscal 2027 results for the quarter ended June 30, 2026 on August 5, 2026 before market open | Kyndryl press release July 1, 2026 and StockAnalysis.com earnings calendar | August 4, 2026 |
| Employees | Approximately 72,000 employees | StockAnalysis.com company profile | August 4, 2026 |
| Technical snapshot | 5-day moving average near $13.67, 20-day moving average near $12.45, 50-day moving average near $12.01, and 200-day moving average near $17.86 as of August 3, 2026, with 14-day RSI near 66.70 and 20-day average volume near 3.90 million shares | StockAnalysis.com statistics and daily price history | August 4, 2026 |